EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CRISPR/Cas9 genome engineering in PDAC: From preclinical studies to translation and clinical research

Yanxi Lu, Jojanneke Stoof, Yaba Rosette Tanoé, Naomi Walsh, Maarten F Bijlsma, Huijun Lei, Tianhui Chen, Jelena Grahovac, Robert Grützmann, Christian Pilarsky

Seminars in Cancer Biology · 2025

DOI: 10.1016/j.semcancer.2025.07.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2025. Verfasst von Yanxi Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen 91054, Germany. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Gene Editing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR/Cas9 technology has emerged as a powerful tool in pancreatic ductal adenocarcinoma cancer (PDAC) research, facilitating the study of genes involved in cell signaling pathways, proliferation, migration, invasion, and chemotherapy resistance. In this review, we discuss the evolution of CRISPR technologies from sophisticated editing techniques to broad screening methods, examine the utility of isogenic models and genetically engineered mouse models (GEMMs). We also explore how CRISPR/Cas9 screens can reveal immune-tumor cell interactions, highlighting the multifaceted role of this technology in PDAC research. Moreover, we emphasize the use of CRISPR technology in diagnostics for CAR-T cell therapies, where CRISPR/Cas9 enhances the precision of targeting malignant cells while minimizing off-tumor effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsCarcinoma, Pancreatic DuctalPancreatic NeoplasmsGene EditingHumansAnimalsTranslational Research, BiomedicalDisease Models, AnimalGenetic EngineeringMice

Stichwörter der Autor:innen

CRISPR/Cas9 Genome EngineeringGEMMsPancreatic Ductal AdenocarcinomaPreclinical studies

Autor:innen und Institutionen

  • Department of Surgery, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen 91054, Germany.
  • Dublin City University, School of Biotechnology, Dublin, Ireland.
  • Faculty of sciences, Friedrich-Alexander-Universität Erlangen Nürnberg, Erlangen 91054, Germany.
  • Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Meibergdreef 9, Amsterdam, the Netherlands; Cancer Center Amsterdam,…
  • Department of Cancer Prevention, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China.
  • Experimental Oncology Department, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.

Förderung

  • European Cooperation in Science and Technology

Zitieren

APA

Lu, Y., Stoof, J., Tanoé, Y. R., Walsh, N., Bijlsma, M. F., Lei, H., Chen, T., Grahovac, J., Grützmann, R., & Pilarsky, C. (2025). CRISPR/Cas9 genome engineering in PDAC: From preclinical studies to translation and clinical research. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2025.07.004

Vancouver

Lu Y, Stoof J, Tanoé YR, Walsh N, Bijlsma MF, Lei H, et al. CRISPR/Cas9 genome engineering in PDAC: From preclinical studies to translation and clinical research. Seminars in Cancer Biology. 2025. doi:10.1016/j.semcancer.2025.07.004

BibTeX
@article{Lu2025,
  author = {Lu, Yanxi and Stoof, Jojanneke and Tanoé, Yaba Rosette and Walsh, Naomi and Bijlsma, Maarten F and Lei, Huijun and Chen, Tianhui and Grahovac, Jelena and Grützmann, Robert and Pilarsky, Christian},
  title = {CRISPR/Cas9 genome engineering in PDAC: From preclinical studies to translation and clinical research},
  journal = {Seminars in Cancer Biology},
  year = {2025},
  doi = {10.1016/j.semcancer.2025.07.004}
}
Kostenlos starten →